Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 2004, p. 4693-4702, Vol. 48, No. 12
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.12.4693-4702.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Integron Carrying a Novel Metallo-ß-Lactamase Gene, blaIMP-16, and a Fused Form of Aminoglycoside-Resistant Gene aac(6')-30/aac(6')-Ib': Report from the SENTRY Antimicrobial Surveillance Program
Rodrigo E. Mendes,1,2*
Mark A. Toleman,2
Julival Ribeiro,3
Helio S. Sader,1,4
Ronald N. Jones,4,5 and
Timothy R. Walsh2
Disciplina de Doenças Infecciosas e Parasitárias, Universidade Federal de São Paulo, São Paulo,1
Hospital de Base do Distrito Federal, Brasília, Brazil,3
Department of Pathology & Microbiology, University of Bristol, Bristol, United Kingdom,2
The JONES Group/JMI Laboratories, North Liberty, Iowa,4
Tufts University School of Medicine, Boston, Massachusetts5
Received 19 April 2004/
Returned for modification 26 June 2004/
Accepted 4 September 2004
Since January 2002 Pseudomonas sp. strains resistant to carbapenems and ceftazidime have been routinely screened as part of the SENTRY Antimicrobial Surveillance Program for metallo-ß-lactamase production, and their resistance determinants have been analyzed. Pseudomonas aeruginosa index strain 101-4704, which harbors a novel blaIMP variant, blaIMP-16, was isolated in April 2002 from a 60-year-old man in Brasília, Brazil. blaIMP-16 was found on the chromosome of the P. aeruginosa index strain, and the deduced amino acid sequence (IMP-16) showed the greatest identities to IMP-11 (90.3%) and IMP-8 (89.5%). Sequence analysis revealed that blaIMP-16 was associated with a class 1 integron, which also encoded aminoglycoside-modifying enzymes. Downstream of blaIMP-16 resided an open reading frame, which consisted of a new aminoglycoside-modifying gene, namely, aac(6')-30, which was fused with aac(6')-Ib'. The amino acid sequence of the aac(6')-30 putative protein showed the most identity (52.7%) to the sequence of AAC(6')-29b described previously. The fourth gene cassette constituted aadA1. The steady-state kinetics of IMP-16 demonstrated that the enzyme preferred cephalosporins and carbapenems to penicillins. The main functional difference observed among the kinetic values for IMP-16 compared to those for other IMPs was a lack of cefoxitin hydrolysis and a lower kcat/Km value for imipenem (0.36 µM1 · s1). This report further emphasizes the spread of metallo-ß-lactamase genes and their close association with various aminoglycoside resistance genes.
* Corresponding author. Mailing address: Laboratório Especial de Microbiologia Clínica, Division of Infectious Diseases, Universidade Federal de São Paulo, Rua Leandro Dupret, 188 São Paulo, SP 04025-010, Brazil. Phone: (55-11) 5081-2819. Fax: (55-11) 5571-5180. E-mail:
rodrigo.mendes{at}lemc.com.br.
Antimicrobial Agents and Chemotherapy, December 2004, p. 4693-4702, Vol. 48, No. 12
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.12.4693-4702.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
al Naiemi, N., Rijnsburger, M. C., Savelkoul, P. H. M., Vandenbroucke-Grauls, C. M. J., Debets-Ossenkopp, Y. J.
(2009). Emergence of metallo-{beta}-lactamases in the Netherlands. J Med Microbiol
58: 1398-1399
[Full Text]
-
Strateva, T., Yordanov, D.
(2009). Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol
58: 1133-1148
[Abstract]
[Full Text]
-
Pellegrini, C., Mercuri, P. S., Celenza, G., Galleni, M., Segatore, B., Sacchetti, E., Volpe, R., Amicosante, G., Perilli, M.
(2009). Identification of blaIMP-22 in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location. J Antimicrob Chemother
63: 901-908
[Abstract]
[Full Text]
-
Juan, C., Beceiro, A., Gutierrez, O., Alberti, S., Garau, M., Perez, J. L., Bou, G., Oliver, A.
(2008). Characterization of the New Metallo-{beta}-Lactamase VIM-13 and Its Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in Spain. Antimicrob. Agents Chemother.
52: 3589-3596
[Abstract]
[Full Text]
-
Marchiaro, P., Ballerini, V., Spalding, T., Cera, G., Mussi, M. A., Moran-Barrio, J., Vila, A. J., Viale, A. M., Limansky, A. S.
(2008). A convenient microbiological assay employing cell-free extracts for the rapid characterization of Gram-negative carbapenemase producers. J Antimicrob Chemother
62: 336-344
[Abstract]
[Full Text]
-
Picao, R. C., Andrade, S. S., Nicoletti, A. G., Campana, E. H., Moraes, G. C., Mendes, R. E., Gales, A. C.
(2008). Metallo-{beta}-Lactamase Detection: Comparative Evaluation of Double-Disk Synergy versus Combined Disk Tests for IMP-, GIM-, SIM-, SPM-, or VIM-Producing Isolates. J. Clin. Microbiol.
46: 2028-2037
[Abstract]
[Full Text]
-
Mendes, R. E., Bell, J. M., Turnidge, J. D., Yang, Q., Yu, Y., Sun, Z., Jones, R. N.
(2008). Carbapenem-Resistant Isolates of Klebsiella pneumoniae in China and Detection of a Conjugative Plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 Gene. Antimicrob. Agents Chemother.
52: 798-799
[Full Text]
-
Mendes, R. E., Castanheira, M., Toleman, M. A., Sader, H. S., Jones, R. N., Walsh, T. R.
(2007). Characterization of an Integron Carrying blaIMP-1 and a New Aminoglycoside Resistance Gene, aac(6')-31, and Its Dissemination among Genetically Unrelated Clinical Isolates in a Brazilian Hospital. Antimicrob. Agents Chemother.
51: 2611-2614
[Abstract]
[Full Text]
-
Mendes, R. E., Kiyota, K. A., Monteiro, J., Castanheira, M., Andrade, S. S., Gales, A. C., Pignatari, A. C. C., Tufik, S.
(2007). Rapid Detection and Identification of Metallo-{beta}-Lactamase-Encoding Genes by Multiplex Real-Time PCR Assay and Melt Curve Analysis. J. Clin. Microbiol.
45: 544-547
[Abstract]
[Full Text]
-
Marra, A. R., Pereira, C. A. P., Gales, A. C., Menezes, L. C., Cal, R. G. R., de Souza, J. M. A., Edmond, M. B., Faro, C., Wey, S. B.
(2006). Bloodstream Infections with Metallo-{beta}-Lactamase-Producing Pseudomonas aeruginosa: Epidemiology, Microbiology, and Clinical Outcomes. Antimicrob. Agents Chemother.
50: 388-390
[Abstract]
[Full Text]